Eli Lilly’s acquisition of Janssen Pharmaceutica animal health division to face 22 June EC deadline
Plans by US pharmaceutical company Eli Lilly to acquire Johnson&Johnson’s company Janssen Pharmaceutica’s animal health division are expected to face a 22 June phase I decision deadline by the European Commission.Plans...To view the full article, register now.
Already a subscriber? Click here to view full article